title: [Screening for cervical and breast cancer].
abstract: Screening programs for cervical cancer and breast cancer lead to a clear reduction of mortality. Starting in 2018 screening for cervical cancer will be structured as an organized program as already exists for breast cancer. In future screening for cervical cancer will be primarily performed by human papillomavirus (HPV) testing at intervals of 5 years while cytological examination (Pap smear) will also be available as an additional or alternative procedure. For breast cancer screening in Germany an annual clinical examination with palpation and mammography screening at 2‑year intervals is provided for women aged between 50 and 69 years. In Germany only approximately 50 % of invited women have used the opportunity to participate in screening in recent years. Weighing the benefits against the harms of cancer screening programs is always important in the process of evaluation of different strategies.
authors: Caritas Krankenhaus St. Josef, Universitätsfrauenklinik Regensburg, Landshuter Straße 65, 93053, Regensburg, Deutschland. jwilm@caritasstjosef.de.
authors: J
authors: J
authors: Wilm
authors: Caritas Krankenhaus St. Josef, Universitätsfrauenklinik Regensburg, Landshuter Straße 65, 93053, Regensburg, Deutschland.
authors: S
authors: S
authors: Schüler-Toprak
authors: Caritas Krankenhaus St. Josef, Universitätsfrauenklinik Regensburg, Landshuter Straße 65, 93053, Regensburg, Deutschland.
authors: O
authors: O
authors: Ortmann
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology*; D055088:Early Detection of Cancer; D042241:Early Diagnosis; D005260:Female; D005858:Germany; D006801:Humans; D008327:Mammography; D008875:Middle Aged; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000473:pathology; D011785:Quality Assurance, Health Care; D012307:Risk Factors; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology*; D014626:Vaginal Smears
keywords: Cytology; Human papillomavirus; Prevention; Quality assurance; Screening